BioLife Solutions
BLFS
54 hedge funds and large institutions have $133M invested in BioLife Solutions in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 7 closing their positions.
157% more capital invested
Capital invested by funds: $51.9M → $133M (+$81.4M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
47% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 15
16.06% more ownership
Funds ownership: 30.09% → 46.15% (+16%)
10% more funds holding
Funds holding: 49 → 54 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$28.3M |
| 2 |
SCM
Sandler Capital Management
New York
|
+$12.5M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.94M |
| 4 |
Renaissance Technologies
New York
|
+$4.37M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.14M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$2.06M |
| 3 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$1.31M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.15M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$799K |
BLFS Hedge Fund Activity: Q3 2018 in Review
54 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2018, worth a combined $133M — up 157% from $51.9M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BLFS positions and 7 closed out — a net gain of 5 holders — while 22 added to existing stakes and 15 trimmed.
The largest buyer was Casdin Capital, adding an estimated $28.3M. The largest seller was Deutsche Bank, cutting an estimated $2.14M.
- 54 institutional investors held BioLife Solutions (BLFS) as of Q3 2018, up from 49 in Q2 2018.
- Funds reported $133M of BioLife Solutions stock for Q3 2018, up 157% quarter-over-quarter.
- 12 funds opened new BioLife Solutions positions in Q3 2018 and 7 closed out, a net change of +5 holders.
- The largest BioLife Solutions buyer in Q3 2018 was Casdin Capital, an estimated $28.3M added.
- The largest BioLife Solutions seller in Q3 2018 was Deutsche Bank, an estimated $2.14M sold.
Based on aggregated 13F filings for Q3 2018.